The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Shestakova M.V.

Institut diabeta Éndokrinologicheskogo nauchnogo tsentra, Moskva

Sukhareva O.Iu.

Institut diabeta Éndokrinologicheskogo nauchnogo tsentra, Moskva

Chernova T.O.

FGBU "ndokrinologicheskiĭ nauchnyĭ tsentr" Minzdrava RF

Shmushkovich I.A.

FGBU "Éndokrinologicheskiĭ nauchnyĭ tsentr" MZ RF, Moskva

Aleksandrov A.A.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr Minzdravsotsrazvitiia RF, Moskva

Il'in A.V.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Dedov I.I.

Endocrinology Research Centre

A combination of dipeptidyl peptidase-4 inhibitor and metformin in the treatment of patients with type 2 diabetes mellitus: effective control of glycemia, weight, and quantitative body composition

Authors:

Shestakova M.V., Sukhareva O.Iu., Chernova T.O., Shmushkovich I.A., Aleksandrov A.A., Il'in A.V., Dedov I.I.

More about the authors

Journal: Therapeutic Archive. 2013;85(8): 49‑55

Views: 1719

Downloaded: 255


To cite this article:

Shestakova MV, Sukhareva OIu, Chernova TO, Shmushkovich IA, Aleksandrov AA, Il'in AV, Dedov II. A combination of dipeptidyl peptidase-4 inhibitor and metformin in the treatment of patients with type 2 diabetes mellitus: effective control of glycemia, weight, and quantitative body composition. Therapeutic Archive. 2013;85(8):49‑55. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.